SCHEMBL6909663

SCHEMBL6909663

Cc1cccc(N(C)C)c1O[Zr](Cl)(Cl)Oc1c(C)cccc1N(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.36
MAPT P10636 2/20 0.36
GAA P10253 1/20 0.36
SCN4A P35499 5/20 0.33
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 2/20 0.33
NFKB1 P19838 2/20 0.33
THPO P40225 1/20 0.33
ADRA2A P08913 1/20 0.31
ADRA2B P18089 1/20 0.31
ADRA2C P18825 1/20 0.31
LMNA P02545 3/20 0.31
TSHR P16473 2/20 0.31
SCN1A P35498 2/20 0.31
SCN5A Q14524 2/20 0.31
SCN9A Q15858 2/20 0.31
CYP2C9 P11712 1/20 0.31
KCNK3 O14649 1/20 0.31
CACNA1F O60840 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6902154 0.77 CA2 (0.34) KDM4EMAPTGAAALDH1A1
SCHEMBL6909079 0.77 GABRA1 (0.34) KDM4EMAPTGAACYP1A2CYP3A4
SCHEMBL25066429 0.76 MAPT (0.41) KDM4EMAPTGAASCN4ACYP1A2
SCHEMBL6905327 0.75 KDM4E (0.32) KDM4EMAPTGAA
SCHEMBL6909631 0.75 KDM4E (0.32) KDM4EMAPTGAA
Nitrogen SCHEMBL10979264 0.73 MAPT (0.39) KDM4EMAPTGAASCN4ACYP1A2
Hydrochloric Acid SCHEMBL6909656 0.72 MAPT (0.38) KDM4EMAPTGAASCN4ACYP1A2
Hydrochloric Acid SCHEMBL6909665 0.72 MAPT (0.38) KDM4EMAPTGAASCN4ACYP1A2
SCHEMBL6908459 0.71 MAPT (0.36) KDM4EMAPTGAALMNATSHR
SCHEMBL6906564 0.70 POLB (0.33) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6730626-B2 TRANSITION METAL DERIVATIVE CAN REACT TO FORM AN IONIC COMPLEX WITH THE ALUMINOXANE IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2004-05-04 US disclosed
EP-1323723-A1 TRANSITION METAL COMPOUNDS, POLYMERIZATION CATALYSTS FOR OLEFINS, OLEFIN POLYMERS AND PROCESS FOR THEIR PRODUCTION IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2003-07-02 EP disclosed
US-20020193536-A1 Transition metal compound, polymerization catalysts for olefins, olefin polymers and process for their production IDEMITSU KOSAN CO. LTD. (JP) 2002-12-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193536-A1 Transition metal compound, polymerization catalysts for olefins, olefin polymers and process for their production CCNE2, PYM1, AP1M1 KDM4E 655/4885MAPT 2296/4885GAA 4417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.